NOVEL & NOTEWORTHY

Note worthyNote worthy

ACG MAGAZINE seeks to strengthen readers’ connections to the College and to their GI colleagues and share stories with a focus on members, medicine and meaning. Notable College highlights include March Colorectal Cancer Awareness Month, the North American Conference of GI Fellows, and professional milestones for Dr. Eamonn Quigley, Dr. Prateek Sharma, and Dr. Bryan Green. The College notes with great sadness the death of Dr. Barbara Frank of Philadelphia, a pioneering woman in gastroenterology and former ACG Governor. Email your professional news and any ideas for future issues of ACG MAGAZINE to ACGMag@gi.org

[AWARDEES] Dr. Bryan Green Receives NCCRT National Achievement Award as “Physician Champion”

Dr. Bryan Green of the Digestive Disease Group in Greenwood, South Carolina was recognized by the National Colorectal Cancer Roundtable (NCCRT) for his volunteer contributions to the Colorectal Cancer Prevention Network (CCPN) at the University of South Carolina, a program which provides screening colonoscopies at no cost to uninsured and medically underserved patients. Dr. Green collaborated with the CCPN to develop its comprehensive patient navigation model which increased participation in screening by men and African Americans, and contributed to a reduced colonoscopy no-show rate of less than 1% annually. Significantly, Dr. Green also helped to recruit other gastroenterologists to participate and waive their professional fees.

[COLLEGE NEWS] INTRODUCING THE ACG INNOVATION & TECHNOLOGY COMMITTEE

In the last decade, the practice of gastroenterology has experienced exponential growth in innovation and new technology. Patients are aware and well-informed on these innovations and specifically request them.

To keep our members abreast of the technology and innovations in this evolving landscape, the College created a forum for members to gather information related to new ideas, innovations, and technologies in our field.

The new ACG Innovation & Technology Committee has a multi-faceted mission including generating technology assessment reports, reviews, and white papers related to new technologies and innovations, collaborating with the ACG Hands-on Endoscopy Workshops for training and education, and liaising with industry partners to address current gaps in the device/ innovation realm.

Committee Members: Sarah M. Enslin, PA-C; Seth A. Gross, MD, FACG; Aasma Shaukat, MD, MPH, FACG; Daniel Castaneda, MD; Drew B. Schembre, MD, FACG; Laith H. Jamil, MD, FACG; Marta L. Davila, MD, FACG; Prasad G. Iyer, MD, MS, FACG; Christopher Y. Kim, MD, FACG; Vladimir M. Kushnir, MD; Amandeep K. Shergill, MD, MS; Mark B. Pochapin, MD, FACG; David T. Rubin, MD, FACG; Jay N. Yepuri, MD, MS, FACG; and Committee Chair Vivek Kaul, MD, FACG.

[AWARENESS] MARCH CRC AWARENESS

Tri-Society Hill CRC Event

(1)(7) ACG Trustee Dr. Renee L. Williams represented the College at a Congressional Briefing during March CRC Month with (L to R) AGA President Dr. David A. Lieberman, ASGE Councilor Dr. Jason A. Dominitz, and ASGE President Dr. Steven A. Edmundowicz.

Dr. Balzora with Fight CRC in DC

(2) Dr. Sophie M. Balzora, Chair of the College’s Public Relations Committee was in Washington, DC for two days in March presenting at “Call on Congress,” the annual legislative program of patient and survivor advocates from Fight Colorectal Cancer.

CRC Proclamation Nation

(3) (L to R) Dr. March E. Seabrook, Dr. John Corless, and Dr. Bryan T. Green at the South Carolina State House with a CRC Month Proclamation. (4) Dr. Whitfield L. Knapple (far left) witnesses Arkansas Governor Asa Hutchinson proclaiming March as CRC Month with advocates from the Colon Cancer Coalition and American Cancer Society. (5) Dr. Jeremy Spector, Dr. Samir A. Shah, Dr. Abbas H. Rupawala, and Dr. Harlan Rich at the Rhode Island legislature celebrating the RI CRC Month Proclamation by wearing Blue Star pins for CRC Awareness! (6) Jean S. Wang, MD, PhD, FACG of Washington University in St. Louis (second from Right) with Missouri Governor Mike Parson and CRC advocates.

View More CRC photos: bit.ly/PhotosCRCMonth

6

2

[EDUCATION] FUTURE OF GI

Building presentation skills and cultivating an interest in clinical research among GI fellows-in-training was the goal of the 2019 North American Conference of Gastroenterology Fellows (NACGF) held in April in Florida. NACGF creates opportunities for fellows to present their research in a less pressured environment than at national meetings, interact with senior faculty, and attend excellent educational sessions. Participants compete for a place and have the chance to network and to forge meaningful personal and professional connections. This year’s faculty included Dr. David J. Hass, Dr. Immanuel K. Ho, Dr. Jill K. Gaidos, Dr. Cynthia Levy, and Dr. Philip O. Katz.

[MILESTONES] Prateek Sharma, MD, Named President of the International Society for Diseases of the Esophagus

Prateek Sharma, MD, FACG of The University of Kansas Cancer Center has been named President of The International Society for Diseases of the Esophagus (ISDE). This multidisciplinary international organization is comprised of approximately 1,000 esophageal experts. Dr. Sharma will lead the society’s education and research activities, as well as organize its biennial World Congress on Esophageal Diseases in 2020.

1 5

3

[AWARDEES] DDNC Award to Senator Wicker

Digestive Disease National Coalition (DDNC) President and ACG Treasurer Samir A. Shah, MD, FACG presents the 2019 DDNC Congressional Public Service Award to U.S. Senator Roger Wicker of Mississippi for his efforts regarding removal of barriers to colorectal cancer screening at the DDNC National Public Policy Forum in March. Pictured second from right: ACG’s Costas H. Kefalas, MD, MMM, FACG.

7

[AWARDEES] SCIENCE FOUNDATION IRELAND’S ST PATRICK’S DAY SCIENCE MEDAL AWARDED TO EAMONN M. M. QUIGLEY, MD, MACG

This year, Science Foundation Ireland awarded its academic medal, the St. Patrick’s Day Science Medal, to ACG Past President Eamonn M. M. Quigley, MD, MACG of Houston Methodist Hospital and Weill Cornell Medical School in Houston, Texas. This award recognizes a distinguished Irish scientist, engineer, or technology leader living and working in the United States who is outstanding in their field of expertise and who has also demonstrably assisted researchers in Ireland in either academia or industry—via mentorship, supervision, collaboration, industrial development, entrepreneurship, or who has made significant contributions to developing the research ecosystem in Ireland. In accepting the award, Dr. Quigley, whose long and distinguished career has included academic appointments in both the U.S. and Ireland at the University of Cork, described why he found these translocations easy professionally: “Of course, science speaks one language, but also relevant to my own career as a clinician and clinical researcher is that the fears, hopes, and concerns of the ill are the same everywhere. In caring for the sick, Irish graduates—I believe—do enjoy a distinct advantage. My generation of medical graduates may not, in the past, have been exposed to leading-edge biomedical science, but we did spend a lot of time with the sick and their families in hospitals and in general practices around Ireland. Here we learned to listen to patients, converse about their illness in a language they understood, and from these interactions, develop a plan of clinical care. In other words, the emphasis was on acquiring clinical skills and a bedside manner—characteristics that have served the Irish medical graduate well wherever he or she has practiced medicine.”

 Professor Mark Ferguson (left) formerly of the University of Manchester and now director of SFI; Minister Richard Bruton (middle), presenting Dr. Quigley with the 2019 Science Foundation Ireland St. Patrick’s Day Academic Medal.

[IN MEMORIAM] BARBARA B. FRANK, MD, MACG (1937-2019)

The College mourns the death of Dr. Barbara Balis Frank of Philadelphia, PA on February 21, 2019 and recognizes her pioneering career and leadership. Her family remembers Dr. Frank as a trailblazer throughout her life who excelled at everything she did, and as a loving mother and grandmother.

Dr. Frank joined the College in 1989 and was elected by her peers to serve as ACG Governor for Eastern Pennsylvania from 1992 to 1996, including a term as Regional Councilor from 1994 to 1996. She was elected for another term in 2003. In 2006, Dr. Frank received the ACG Senior Governors Award and also that year was designated a Master of the American College of Gastroenterology. She served for many years on ACG’s Women in GI Committee as well as the Educational Affairs Committee.

Dr. Frank founded the CrozerChester Medical Center’s Division of Gastroenterology in 1968, served as Director of the division until 1989 and continued as an attending until 1994. For many years, Dr. Frank was Clinical Professor of Medicine in the Division of Gastroenterology and Hepatology at Hahnemann/ Medical College of Pennsylvania/ Drexel University College of Medicine in Philadelphia.

Dr. Frank was the first woman to be elected President of the American Society for Gastrointestinal Endoscopy (1991-1992) and received the ASGE Distinguished Educator Award in 2005. In 2006, Drexel University College of Medicine established the Barbara B. Frank, M.D. Endoscopic Learning Resource Center. AGA honored Dr. Frank with the Outstanding Woman Scientist Award in 2008.

Dr. Frank was a member of the Bockus International Society of Gastroenterology, founded in 1959 in honor of Dr. Henry L. Bockus by his former students, residents and fellows at the School of Medicine of the University of Pennsylvania. She served as Bockus Society President from 2009 to 2011.

Her career included longtime service on two key FDA panels, the GI Devices Panel (1988–1994) and the GI Drugs Advisory Committee (1995–1999). Dr. Frank was active in Pennsylvania state and local medical societies and was elected President of the Delaware Valley Phi Beta Kappa Association, serving from 1995 to 1997.

A 1958 magna cum laude graduate of Smith College who majored in Philosophy, Dr. Frank received her M.D. in 1962 from the University of Pennsylvania. She was a resident in internal medicine at Bryn Mawr Hospital and completed her internship and fellowship in gastroenterology at the Hospital of the University of Pennsylvania.

She is survived by her husband of 61 years, Dr. Leonard A. Frank, a urologist whose career included a faculty appointment at Thomas Jefferson University; her sons, Michael Frank and Bradford Frank; as well as three grandchildren, Eliana, Adeline, and Carter Frank.

IMPORTANT SAFETY INFORMATION

SUPREP® Bowel Prep Kit (sodium sulfate, potassium sulfate and magnesium sulfate) Oral Solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. Most common adverse reactions (>2%) are overall discomfort, abdominal distention, abdominal pain, nausea, vomiting and headache. Use is contraindicated in the following conditions: gastrointestinal (GI) obstruction, bowel perforation, toxic colitis and toxic megacolon, gastric retention, ileus, known allergies to components of the kit. Use caution when prescribing for patients with a history of seizures, arrhythmias, impaired gag reflex, regurgitation or aspiration, severe active ulcerative colitis, impaired renal function or patients taking medications that may affect renal function or electrolytes. Use can cause temporary elevations in uric acid. Uric acid fluctuations in patients with gout may precipitate an acute flare. Administration of osmotic laxative products may produce mucosal aphthous ulcerations, and there have been reports of more serious cases of ischemic colitis requiring hospitalization. Patients with impaired water handling who experience severe vomiting should be closely monitored including measurement of electrolytes. Advise all patients to hydrate adequately before, during, and after use. Each bottle must be diluted with water to a final volume of 16 ounces and ingestion of additional water as recommended is important to patient tolerance.

BRIEF SUMMARY: Before prescribing, please see Full Prescribing Information and Medication Guide for SUPREP® Bowel Prep Kit (sodium sulfate, potassium sulfate and magnesium sulfate) Oral Solution. INDICATIONS AND USAGE: An osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. CONTRAINDICATIONS: Use is contraindicated in the following conditions: gastrointestinal (GI) obstruction, bowel perforation, toxic colitis and toxic megacolon, gastric retention, ileus, known allergies to components of the kit. WARNINGS AND PRECAUTIONS: SUPREP Bowel Prep Kit is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. Use is contraindicated in the following conditions: gastrointestinal (GI) obstruction, bowel perforation, toxic colitis and toxic megacolon, gastric retention, ileus, known allergies to components of the kit. Use caution when prescribing for patients with a history of seizures, arrhythmias, impaired gag reflex, regurgitation or aspiration, severe active ulcerative colitis, impaired renal function or patients taking medications that may affect renal function or electrolytes. Pre-dose and post-colonoscopy ECGs should be considered in patients at increased risk of serious cardiac arrhythmias. Use can cause temporary elevations in uric acid. Uric acid fluctuations in patients with gout may precipitate an acute flare. Administration of osmotic laxative products may produce mucosal aphthous ulcerations, and there have been reports of more serious cases of ischemic colitis requiring hospitalization. Patients with impaired water handling who experience severe vomiting should be closely monitored including measurement of electrolytes. Advise all patients to hydrate adequately before, during, and after use. Each bottle must be diluted with water to a final volume of 16 ounces and ingestion of additional water as recommended is important to patient tolerance. Pregnancy: Pregnancy Category C. Animal reproduction studies have not been conducted. It is not known whether this product can cause fetal harm or can affect reproductive capacity. Pediatric Use: Safety and effectiveness in pediatric patients has not been established. Geriatric Use: Of the 375 patients who took SUPREP Bowel Prep Kit in clinical trials, 94 (25%) were 65 years of age or older, while 25 (7%) were 75 years of age or older. No overall differences in safety or effectiveness of SUPREP Bowel Prep Kit administered as a split-dose (2-day) regimen were observed between geriatric patients and younger patients. DRUG INTERACTIONS: Oral medication administered within one hour of the start of administration of SUPREP may not be absorbed completely. ADVERSE REACTIONS: Most common adverse reactions (>2%) are overall discomfort, abdominal distention, abdominal pain, nausea, vomiting and headache. Oral Administration: Split-Dose (Two-Day) Regimen: Early in the evening prior to the colonoscopy: Pour the contents of one bottle of SUPREP Bowel Prep Kit into the mixing container provided. Fill the container with water to the 16 ounce fill line, and drink the entire amount. Drink two additional containers filled to the 16 ounce line with water over the next hour. Consume only a light breakfast or have only clear liquids on the day before colonoscopy. Day of Colonoscopy (10 to 12 hours after the evening dose): Pour the contents of the second SUPREP Bowel Prep Kit into the mixing container provided. Fill the container with water to the 16 ounce fill line, and drink the entire amount. Drink two additional containers filled to the 16 ounce line with water over the next hour. Complete all SUPREP Bowel Prep Kit and required water at least two hours prior to colonoscopy. Consume only clear liquids until after the colonoscopy. STORAGE: Store at 20°-25°C (68°-77°F). Excursions permitted between 15°-30°C (59°-86°F). Rx only. Distributed by Braintree Laboratories, Inc. Braintree, MA 02185

For additional information, please call 1-800-874-6756 or visit www.suprepkit.com

#1 MOST PRESCRIBED,

BRANDED BOWEL PREP KIT1

WITH MORE THAN 15 MILLION KITS DISPENSED SINCE 20101

A CLEAN SWEEP

EFFECTIVE RESULTS IN ALL COLON SEGMENTS2

· SUPREP® Bowel Prep Kit has been FDA-approved as a split-dose oral regimen3 · >90% of patients had no residual stool in all colon segments2*†

These cleansing results for the cecum included 91% of patients2*†

SUPREP Bowel Prep Kit also achieved ≥64% no residual fl uid in 4 out of 5 colon segments (ascending, transverse, descending, and sigmoid/rectum)2*†

Aligned with Gastrointestinal Quality Improvement Consortium (GIQuIC) performance target of ≥85% quality cleansing for outpatient colonoscopies.4

*This clinical trial was not included in the product labeling. †Based on investigator grading. References: 1. IQVIA. National Prescription Audit Report. September 2018. 2. Rex DK, DiPalma JA, Rodriguez R, McGowan J, Cleveland M. A randomized clinical study comparing reduced-volume oral sulfate solution with standard 4-liter sulfate-free electrolyte lavage solution as preparation for colonoscopy. Gastrointest Endosc. 2010;72(2):328-336. 3. SUPREP Bowel Prep Kit [package insert]. Braintree, MA: Braintree Laboratories, Inc; 2017. 4. Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015;81(1):31-53.

JUNE 7

HEPATOLOGY SCHOOL AT EASTERN REGIONAL  Washington, DC

Register: gi.org/regional-meetings

JUNE 8–9

EASTERN REGIONAL POSTGRADUATE COURSE  Washington, DC

Register: gi.org/regional-meetings

JULY 19

EDGAR ACHKAR VISITING PROFESSORSHIP APPLICATION DEADLINE

Apply Now: gi.org/acg-institute/application

AUGUST 16

AUGUST 17–18

IBD SCHOOL AT MIDWEST REGIONAL

 Minneapolis, MN

Learn More: gi.org/regional-meetings

MIDWEST REGIONAL POSTGRADUATE COURSE

 Minneapolis, MN

Learn More: gi.org/regional-meetings

Learn More: acgmeetings.gi.org

JULY 12

YOUNG PHYSICIAN LEADERSHIP SCHOLARS PROGRAM APPLICATION DEADLINE

Apply Now: gi.org/young-physicians

SEPTEMBER 6

FUNCTIONAL GI DISORDERS SCHOOL AT ACG/VGS/ODSGNA REGIONAL  Williamsburg, VA

Learn More: gi.org/regional-meetings

SEPTEMBER 7–8

ACG/VGS/ODSGNA REGIONAL POSTGRADUATE COURSE  Williamsburg, VA

Learn More: gi.org/regional-meetings

DECEMBER 6-8

HEPATOLOGY SCHOOL & SOUTHERN REGIONAL POSTGRADUATE COURSE  Louisville, KY

Learn More: gi.org/regional-meetings

From the Updated ACG STRATEGIC PLAN 1 2 3 4 5 6 7 8 9 10

Satisfy the needs of our membership and profession through adherence to our mission and vision. The strength of the organization fl ows through the provision of services to a diverse group of clinicians who strive to provide the optimal care for their patients with digestive diseases and disorders.

Support members and develop leaders who embody the values of integrity, honesty, and professionalism to form the governance of the College, emulate our mission and vision, ensure social and fi scal responsibility of the a airs of the College, and represent the diverse interests and needs of the membership.

Create and deliver timely and relevant educational activities and academic opportunities, through a variety of innovative platforms enhancing best practices in patient care, practice management, and leadership in gastroenterology and hepatology.

Promote the academic achievements of our profession by providing premier journal o erings and a robust and comprehensive annual meeting at no charge to our members.

Support and foster a wide variety of clinical and translational research opportunities to students, trainees and researchers through increases in funding of scholarships, awards and grants, and develop resources to strengthen the understanding of clinical research methods and promote scientifi c collaboration and impactful discoveries.

Promote and emphasize the importance of quality by establishing metrics, measuring outcomes, and providing leadership to enhance and evolve systems for measuring, researching , and improving quality improvement in the fi eld of gastroenterolog y.

Create a powerful voice in all areas of national a airs and public policy to advocate for all our members, improve the practice of medicine , and enhance the health and well-being of our patient s.

Embrace the values of camaraderie, mutual trust, and respect within a diverse professional organization composed of voluntary executive o cers, board of trustees, board of governors, administration, and our members.

Enhance the professional satisfaction of our members by acknowledging and attenuating the impact of burnout, and acknowledging the importance of wellness and professionalism.

Strengthen partnerships and alliances with national and international organizations to improve the GI health of all populations through education, research , and advocac y.